- Report
- June 2026
- 110 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- June 2026
- 188 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- April 2026
- 180 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- April 2026
- 110 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- January 2026
- 140 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- April 2026
- 180 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- April 2026
- 120 Pages
Global
From €4282EUR$4,750USD£3,679GBP
- Report
- July 2026
- 160 Pages
Global
From €2993EUR$3,320USD£2,571GBP
€3741EUR$4,150USD£3,214GBP
- Report
- December 2025
- 52 Pages
Global
From €6761EUR$7,500USD£5,809GBP
- Report
- February 2026
- 200 Pages
Global
From €4503EUR$4,995USD£3,869GBP
- Report
- February 2026
- 200 Pages
Global
From €4503EUR$4,995USD£3,869GBP
- Report
- February 2026
- 200 Pages
Global
From €4503EUR$4,995USD£3,869GBP
- Report
- July 2026
- 160 Pages
Global
From €2993EUR$3,320USD£2,571GBP
€3741EUR$4,150USD£3,214GBP
- Report
- May 2026
- 156 Pages
Global
From €3561EUR$3,950USD£3,059GBP
- Report
- April 2026
- 173 Pages
Global
From €4372EUR$4,850USD£3,756GBP
- Report
- July 2026
- 150 Pages
Global
From €4372EUR$4,850USD£3,756GBP
- Report
- April 2026
- 170 Pages
Global
From €4372EUR$4,850USD£3,756GBP
- Report
- February 2026
- 180 Pages
Global
From €4372EUR$4,850USD£3,756GBP
- Report
- February 2026
- 184 Pages
Global
From €4372EUR$4,850USD£3,756GBP
- Report
- February 2026
- 202 Pages
Global
From €4372EUR$4,850USD£3,756GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more